manufacturers of glp 1 drugs GLP-1 Receptor Agonist Market Size Poll: 1 in 8 Adults

has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Pharmaserve Lilly and Novo Nordisk, for advisory boards from Novo Nordisk, and has participated in sponsored studies by Eli-Lilly and Novo Nordisk

They are also not recommended in individuals with certain conditions such as inflammatory bowel disease, pancreatitis, personal or family history of medullary thyroid cancer or multiple endocrine neoplasia

[DOI] [PubMed] [Google Scholar] 15

Below are examples of GLP-1 agonists commonly prescribed for diabetes or weight loss

It remains to be seen what share of the costs of weight-loss drugs will be borne by patients or payers

This opens the door for generic versions